Please login to the form below

Not currently logged in
Email:
Password:

Sygnature Discovery

This page shows the latest Sygnature Discovery news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Dr Edward Browne joins Sygnature Discovery Dr Edward Browne joins Sygnature Discovery

    He becomes associate director of drug metabolism and pharmacokinetics. Nottingham, UK-based Sygnature Discovery has expanded its drug metabolism and pharmacokinetics (DMPK) team with the appointment of Dr Edward Browne as ... Dr Timothy Schulz-Utermoehl,

  • Sygnature Discovery expands business and bioscience teams Sygnature Discovery expands business and bioscience teams

    Sygnature Discovery has appointed Dr Stephen Young and Dr Stuart Thomson to its senior business and bioscience teams. ... Meanwhile, Dr Stuart Thomson (pictured left) joins Sygnature Discovery as associate director of bioscience.

  • Industry veteran Louis Nisbet joins Sygnature board Industry veteran Louis Nisbet joins Sygnature board

    Brings experience from Roche, Glaxo and SmithKline. Sygnature Discovery has appointed Dr Louis Nisbet to its board as a non-executive director. ... Sygnature's CEO Dr Simon Hirst commented that Dr Nisbet joins the board at a time of growth for the company

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics